Skip to main content
B

Brother Enterprises Holding Co.,Ltd. — Investor Relations & Filings

Ticker · 002562 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2026-04-20 Share Issue/Capital Cha…
Country CN China
Listing Shenzhen Stock Exchange 002562

About Brother Enterprises Holding Co.,Ltd.

https://www.brother.com.cn

Brother Enterprises Holding Co., Ltd. specializes in the development and large-scale production of fine chemicals, with a primary focus on vitamins and leather processing agents. The company’s core product range includes Vitamin K3, Vitamin B1, Vitamin B3 (Niacin and Niacinamide), and Vitamin B5, catering to the global animal nutrition, human food, and pharmaceutical industries. It also manufactures chrome salts and specialized tanning chemicals for the leather sector. By maintaining an integrated production chain, the company ensures high-quality standards and supply chain reliability. It holds a leading position in the global Vitamin K3 market and leverages advanced manufacturing technologies to serve a diverse international clientele across multiple continents.

Recent filings

Filing Released Lang Actions
国泰海通证券股份有限公司关于兄弟科技股份有限公司向特定对象发行股票限售股份解除限售上市流通的核查意见
Share Issue/Capital Change Classification · 1% confidence The document is a sponsor’s verification opinion (“核查意见”) regarding the issuance of A-shares to specific target investors and the lifting of the lock-up period for those restricted shares. It details the share issuance, the shares to be unlocked for trading, the changes in total share capital, and confirms compliance with listing rules. This is not an earnings release or annual report, but rather a capital change announcement related to a targeted share issuance and lock-up release. Hence it falls under Share Issue/Capital Change (Code: SHA).
2026-04-20 Chinese
关于向特定对象发行股票限售股份解除限售上市流通的提示性公告
Share Issue/Capital Change Classification · 1% confidence The document is an official announcement by Brothers Technology (stock code 002562) regarding the lifting of lock-up restrictions on 79,121,376 shares previously issued to specific investors and their upcoming listing for free trading on April 24, 2026. It details the number of shares, shareholders involved, lock-up period, and post-unlock capital structure changes. This is not a standalone earnings release, management report, or regulatory reference to an annual/interim report; rather it pertains to a corporate action affecting share capital structure. The appropriate category is Share Issue/Capital Change (Code: SHA).
2026-04-20 Chinese
关于公司控股股东、实际控制人提前终止股份减持计划暨减持股份结果的公告
Regulatory Filings
2026-04-07 Chinese
关于控股股东、实际控制人股份解除质押的公告
Regulatory Filings
2026-04-07 Chinese
关于诉讼事项的进展公告
Regulatory Filings
2026-04-01 Chinese
关于诉讼事项的进展公告
Regulatory Filings
2026-03-02 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.